Solvent Evaporation Market By Equipment Type (Rotary Evaporators, Centrifugal Evaporators, Nitrogen Blowdown Systems, Vacuum-Based Evaporators); By Application (Pharmaceutical Development, Polymer & Material Synthesis, Environmental & Analytical Testing, Food & Beverage R&D); By End User (Pharmaceutical & Biotech Companies, CDMOs, Academic Labs, Environmental Testing Facilities, Chemical Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Solvent Evaporation Market: Automation, Precision and Safer Sample Concentration Reshape Laboratory Workflows – (Updated On: 17-Aug-2026)

The Global Solvent Evaporation Market was valued at USD 716.8 million in 2025 and is projected to reach USD 1.12 billion by 2032, growing at a CAGR of 6.6% during 2026–2032, according to Strategic Market Research.

 

What Is Driving the Demand for Solvent Evaporation Systems?

Solvent evaporation is the controlled removal of liquid solvents from laboratory samples, reaction mixtures and extracts through heat, vacuum, centrifugal force, gas flow or a combination of these methods. It is commonly used for sample concentration, solvent exchange, drying, purification and recovery before further synthesis or instrumental analysis. Demand is increasing as pharmaceutical, biotechnology, chemical, environmental and food laboratories process more samples while trying to reduce manual handling. Laboratories increasingly prefer systems that provide controlled evaporation, protect sensitive samples, support parallel processing and reduce analyst time. Automation of sample preparation is also increasing the importance of evaporators that can integrate smoothly with extraction, purification and analytical workflows.

 

How Do Regulations and Standards Shape Solvent Evaporation Demand?

Pharmaceutical and analytical laboratories operate under requirements that indirectly strengthen demand for controlled solvent evaporation. In the U.S., FDA's implementation of ICH Q3C(R8) establishes permitted exposure principles for residual solvents in pharmaceuticals, while USP General Chapter <467> Residual Solvents defines controls for organic volatile chemicals used or produced during pharmaceutical manufacturing. These requirements encourage pharmaceutical laboratories to use reproducible solvent-removal and analytical workflows rather than uncontrolled evaporation methods.

 

U.S. EPA Method 533 specifies that sample extracts used for PFAS analysis are concentrated to dryness under a gentle nitrogen stream before reconstitution, directly supporting controlled nitrogen evaporation in applicable testing laboratories.

 

Laboratory safety also influences equipment selection. OSHA's Laboratory Standard covers occupational exposure to hazardous chemicals, while its requirements and guidance for flammable liquids and ventilation reinforce the need for controlled handling of volatile solvents. Globally, adoption of ICH residual-solvent principles across major pharmaceutical markets similarly favors systems with reliable vacuum control, vapor capture and repeatable operating conditions.

 

Why Are Different Solvent Evaporation Equipment Types Gaining Demand?

Rotary evaporators held the largest equipment share at 38.0% in 2025, representing USD 272.4 million, and are projected to grow at a CAGR of 5.9%. Demand remains strong because these systems support routine concentration, solvent recovery, crystallization and synthesis across research and quality-control laboratories. For example, BUCHI and IKA provide integrated rotary evaporation platforms combining evaporation, vacuum and related accessories, helping laboratories replace fragmented setups with controlled systems for frequent solvent-processing work.

 

Centrifugal evaporators accounted for 23.0% of the market in 2025, valued at USD 164.9 million, and have the fastest equipment CAGR at 7.4%. Demand is increasing because drug discovery, genomics, and analytical laboratories require high-throughput, parallel sample concentration with minimal loss, and these systems enable gentle, uniform evaporation of multiple small-volume samples in microplates and tubes while reducing bumping and improving reproducibility, making them well suited for automated workflows.

 

Vacuum-based evaporators represented 22.0% of revenue in 2025, equivalent to USD 157.7 million, and are projected to grow at 7.1%. Their growth is supported by laboratories that need gentle solvent removal at reduced temperatures, particularly when samples may be affected by excessive heat.

 

Nitrogen blowdown systems held a 17.0% share in 2025, valued at USD 121.9 million, and are forecast to expand at a 6.8% CAGR. Demand is supported by environmental, toxicology, food and analytical laboratories that concentrate extracted samples before instrumental testing. Their straightforward parallel-processing format remains valuable where established analytical methods specify or accommodate gentle nitrogen evaporation, including EPA PFAS testing workflows.

 

Is the Solvent Evaporation Market Becoming More Automated, Safer and More Energy-Efficient?

The solvent evaporation market is advancing through equipment engineering rather than major changes to evaporation fundamentals. Laboratories still rely on vacuum, heat, gas flow, rotation and surface-area control to accelerate solvent removal, but manufacturers are integrating these principles into systems that improve throughput, repeatability and operator safety. Organomation notes that reduced pressure lowers solvent boiling points, while nitrogen blowdown continuously removes solvent-saturated vapor above a sample, supporting faster concentration.

 

Automation is becoming a major product differentiator. Porvair Sciences’ Ultravap Levante is designed for robot-compatible dry-down workflows and supports 12-, 24-, 48-, 96- and 384-position needle heads. Its RS232 interface and remote command set allow integration with robotic liquid-handling platforms, while programmable evaporation steps and stored methods support standardized high-throughput sample preparation. This reflects demand from drug-discovery and analytical laboratories seeking to reduce manual plate handling.

 

Safety and certification are also shaping equipment upgrades. Across International’s 20 L SolventVap rotary evaporators are ETL tested to UL and CSA standards and incorporate vacuum operation and covered heating baths. The bath cover is designed to improve temperature uniformity while reducing heat loss, connecting safety improvements with energy efficiency.

 

Manufacturers are also expanding alternatives to conventional water baths. Organomation offers dry-block nitrogen evaporators operating from 30–120 °C, providing higher-temperature capability and avoiding water-bath handling. BioChromato’s Smart Evaporator takes another approach through Vacuum Vortex Concentration and a proprietary Spiral Plug, creating vortex airflow that increases solvent surface area and reduces bumping, including with difficult high-boiling solvents such as DMSO and DMF.

 

Throughput remains another competitive area. Biotage TurboVap systems, distributed by Norlab, combine controlled heating and gas-vortex shearing, with selected configurations offering endpoint concentration. Asynt’s DrySyn Spiral Evaporator enables parallel sample evaporation while reducing bumping.

 

Together, these developments suggest competition is shifting toward robotic integration, programmable workflows, certified safety, compact dry heating, solvent containment and lower-maintenance operation. Future differentiation will increasingly depend on how efficiently equipment automates solvent removal while protecting samples, operators and laboratory resources.

 

Why Is Pharmaceutical Development the Largest Application for Solvent Evaporation?

Pharmaceutical development was the largest application with 39.0% market share in 2025, generating USD 279.6 million and expanding at a 7.2% CAGR. Evaporation is repeatedly required during medicinal chemistry, purification, compound concentration, analytical method development and formulation. For example, BUCHI and Biotage provide evaporation systems positioned for pharmaceutical, bioanalytical and sample-preparation workflows, helping researchers handle solvent removal more consistently as laboratory throughput increases.

 

Polymer and material synthesis accounted for 23.0% of the market in 2025, valued at USD 164.9 million, and is projected to grow at a 6.7% CAGR. Demand is increasing because solution-based synthesis, purification, coating formulations and material-development experiments commonly require solvent concentration or recovery. Firms such as IKA and Heidolph provide rotary evaporation systems suited to frequent chemical laboratory distillation and solvent-processing tasks, supporting researchers that need flexible systems across changing synthesis conditions.

 

Environmental and analytical testing represented 21.0% of revenue in 2025, or USD 150.5 million, and is expected to grow at a 6.2% CAGR. Laboratories use evaporation to concentrate extracts before chromatographic and mass-spectrometric analysis. Demand is supported by testing workflows in which very low analyte concentrations require controlled sample preparation, particularly contaminant, residue and PFAS analysis.

 

Food and beverage R&D held 17.0% of the market in 2025, representing USD 121.9 million, with a CAGR of 5.6%. Growth is supported by laboratories concentrating extracts during flavor, residue, contaminant and compositional analysis. Demand remains comparatively moderate because food laboratories use several alternative sample-preparation approaches, but solvent evaporation continues to be useful where researchers need concentration or solvent exchange before instrumental analysis.

 

Why Are Pharmaceutical Companies and CDMOs Important Solvent Evaporation End Users?

Pharmaceutical and biotechnology companies led end-user demand with a 36.0% share in 2025, representing USD 258.0 million, and are projected to grow at a 7.0% CAGR. Evaporation systems are used across medicinal chemistry, bioanalysis, process development and quality laboratories. For instance, Biotage and Thermo Fisher Scientific provide evaporation and concentration systems designed around bioanalytical, drug-discovery and laboratory sample-preparation workflows, supporting demand for higher-throughput processing with less manual intervention.

 

CDMOs accounted for 21.0% of revenue in 2025, valued at USD 150.5 million, and record the fastest end-user CAGR at 7.7%. Their demand is increasing because the same laboratory infrastructure can support multiple client molecules, development programs and analytical methods. Providers such as Lonza and Thermo Fisher Scientific's Patheon business operate across drug development and manufacturing, making flexible synthesis and analytical infrastructure commercially important as outsourced pharmaceutical activity expands.

 

Academic laboratories represented 16.0% of the market in 2025, or USD 114.7 million, and are projected to grow at 5.5%. Universities and research institutes use solvent evaporators across chemistry, life sciences, materials research and environmental studies. Demand is primarily supported by replacement purchases, new research laboratories and the need for versatile equipment that can support multiple projects rather than highly specialized production workflows.

 

Environmental testing facilities held a 14.0% share in 2025, valued at USD 100.4 million, and are forecast to grow at a 6.3% CAGR, driven by stricter environmental regulations, rising demand for water, soil, and air quality monitoring, increasing PFAS and contaminant testing requirements, and expanded industrial compliance and environmental surveillance activities.

 

Chemical manufacturers accounted for 13.0% of revenue in 2025, equivalent to USD 93.2 million, and are expected to grow at a 5.8% CAGR. These users purchase evaporation equipment for synthesis development, solvent recovery, purification and product-development laboratories. Growth remains steady as chemical producers seek more controlled solvent handling while larger-scale industrial evaporation equipment remains outside the scope of this laboratory-focused market.

 

Why Does North America Lead While Asia Pacific Grows Faster?

North America led the solvent evaporation market with a 36.0% share in 2025, valued at USD 258.0 million, and is projected to grow at a 6.2% CAGR. Demand is supported by the region's pharmaceutical, biotechnology, contract-research, environmental-testing and academic laboratory base. For example, Thermo Fisher Scientific and Labconco provide centrifugal and vacuum concentration platforms for drug discovery, biological research and analytical chemistry, giving laboratories multiple configurations as sample throughput and automation requirements increase.

 

Europe accounted for 29.0% of the market in 2025, representing USD 207.9 million, and is forecast to grow at a 5.9% CAGR. Demand is sustained by pharmaceutical development, specialty chemical research and established academic laboratories that routinely use solvent concentration and recovery. Companies such as BUCHI, Heidolph and IKA offer rotary evaporation systems with integrated vacuum, cooling and automation options, supporting laboratories replacing manual setups with more controlled evaporation workflows.

 

Asia Pacific held 25.0% of revenue in 2025, valued at USD 179.2 million, and records the fastest regional CAGR at 8.1%. Growth is supported by expanding pharmaceutical development, contract research, chemical laboratories and university research across major Asian markets. Increasing installation of modern analytical and synthesis equipment is widening the addressable base for rotary, vacuum and centrifugal evaporation systems.

 

Latin America represented 6.0% of the market in 2025, or USD 43.0 million, and is expected to grow at a 6.5% CAGR. Demand is developing around pharmaceutical quality control, food testing, universities and environmental laboratories. Adoption remains more concentrated than in North America or Europe, with purchases often linked to laboratory modernization and replacement of basic manual solvent-processing setups.

 

The Middle East & Africa accounted for 4.0% of market revenue in 2025, valued at USD 28.7 million, and is projected to grow at a 5.7% CAGR. Demand primarily comes from universities, pharmaceutical quality laboratories, petrochemical research and environmental testing. Growth is expected to remain selective, with purchases concentrated in research centers and industrial laboratories that require controlled sample concentration and solvent recovery.

 

How Is Competition Evolving in the Solvent Evaporation Market?

Competition centers on evaporation control, sample protection, automation, solvent compatibility and workflow integration rather than evaporation speed alone. Suppliers differentiate through complete systems that combine evaporators with vacuum pumps, condensers, cold traps, gas-management components, software and application-specific accessories.

 

BUCHI

BUCHI maintains a broad rotary evaporation portfolio led by the Rotavapor family. Its systems range from laboratory platforms for routine concentration, reflux and recrystallization to larger configurations for pharmaceutical and chemical applications. The company also offers vacuum controllers, pumps, chillers and accessories that allow customers to build integrated evaporation workflows.

 

Thermo Fisher Scientific

Thermo Fisher Scientific competes strongly in centrifugal evaporation through its Savant SpeedVac portfolio. Its product range includes compact, medium-capacity, large-capacity and integrated concentrator systems, together with vacuum pumps and refrigerated vapor traps. The platform addresses biological, pharmaceutical, combinatorial chemistry and analytical sample-concentration requirements.

 

Biotage

Biotage focuses on automated nitrogen-based evaporation and high-throughput sample preparation through the TurboVap portfolio. Its systems cover tube and microplate workflows and are integrated with broader extraction and bioanalytical sample-preparation solutions. This positions the company particularly well in laboratories seeking to connect extraction, evaporation and subsequent LC-MS analysis.

 

Heidolph

Heidolph offers the Hei-VAP family of benchtop rotary evaporators together with matched vacuum pumps, chillers and automation modules. Its portfolio spans basic laboratory evaporation through more automated configurations, allowing chemistry and research laboratories to select systems according to solvent volume, operating control and solvent-recovery requirements.

 

Labconco

Labconco competes primarily through its CentriVap centrifugal vacuum concentrator portfolio. The systems combine centrifugal force, vacuum and controlled heat and can be configured with cold traps, pumps and different rotors. Their application range includes drug discovery, molecular biology, proteomics, analytical chemistry and other multi-sample concentration workflows.

 

IKA

IKA's solvent evaporation portfolio centers on its RV 10 rotary evaporator family. The company offers basic, digital and automated configurations as well as complete packages combining rotary evaporation with vacuum equipment and other supporting components. The portfolio addresses routine and high-demand distillation work in chemistry, research and product-development laboratories.

 

Solvent Evaporation Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 716.8 Million
Revenue Forecast in 2032	USD 1.12 Billion
Overall Growth Rate	CAGR of 6.6% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Equipment Type, Application, End User, Geography
By Equipment Type	Rotary Evaporators, Centrifugal Evaporators, Nitrogen Blowdown Systems, Vacuum-Based Evaporators
By Application	Pharmaceutical Development, Polymer & Material Synthesis, Environmental & Analytical Testing, Food & Beverage R&D
By End User	Pharmaceutical & Biotech Companies, CDMOs, Academic Labs, Environmental Testing Facilities, Chemical Manufacturers
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Market Drivers	Rising demand for controlled and reproducible solvent removal across pharmaceutical, biotechnology, chemical and analytical laboratories. Growing adoption of automated and high-throughput sample preparation workflows in drug discovery, bioanalysis and environmental testing. Increasing focus on solvent safety, residual-solvent control, vapor containment and efficient laboratory processing.
Customization Option	Available upon request